Mark A. Robinson

Array ( [id] => 8708657 [patent_doc_number] => 20130065946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'Materials and Methods Related to Modulation of Mismatch Repair and Genomic Stability by miR-155' [patent_app_type] => utility [patent_app_number] => 13/637490 [patent_app_country] => US [patent_app_date] => 2011-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16236 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13637490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7579770 [patent_doc_number] => 20110293653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'ANTAGONISTS OF MIR-155 FOR THE TREATMENT OF INFLAMMATORY LIVER DISEASE' [patent_app_type] => utility [patent_app_number] => 13/046534 [patent_app_country] => US [patent_app_date] => 2011-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 17437 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20110293653.pdf [firstpage_image] =>[orig_patent_app_number] => 13046534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8523453 [patent_doc_number] => 20120322862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-20 [patent_title] => 'Aptamers to 4-1BB and Their Use in Treating Diseases and Disorders' [patent_app_type] => utility [patent_app_number] => 13/582332 [patent_app_country] => US [patent_app_date] => 2011-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13711 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13582332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733692 [patent_doc_number] => 20120016004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'COMPOSITIONS FOR INHIBITING GENE EXPRESSION AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/038924 [patent_app_country] => US [patent_app_date] => 2011-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 18612 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20120016004.pdf [firstpage_image] =>[orig_patent_app_number] => 13038924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7484716 [patent_doc_number] => 20110250260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'INHIBITION OF BRAIN ENZYMES INOLVED IN CEREBRAL AMYLOID ANGIOPATHY AND MACULAR DEGENERATION' [patent_app_type] => utility [patent_app_number] => 13/035658 [patent_app_country] => US [patent_app_date] => 2011-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11239 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20110250260.pdf [firstpage_image] =>[orig_patent_app_number] => 13035658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8697897 [patent_doc_number] => 20130059906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => 'METHODS AND COMPOSITIONS FOR INFLUENCING TUMORS USING MICRORNA-185 AS A TUMOR SUPPRESSOR' [patent_app_type] => utility [patent_app_number] => 13/579789 [patent_app_country] => US [patent_app_date] => 2011-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9115 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13579789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8697893 [patent_doc_number] => 20130059902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => 'METHODS AND COMPOSITIONS USEFUL IN TREATMENT OF DISEASES OR CONDITIONS RELATED TO REPEAT EXPANSION' [patent_app_type] => utility [patent_app_number] => 13/577648 [patent_app_country] => US [patent_app_date] => 2011-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28538 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13577648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6167864 [patent_doc_number] => 20110196016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'Compositions and Methods for Inhibiting Expression of IKK2 Genes' [patent_app_type] => utility [patent_app_number] => 13/018471 [patent_app_country] => US [patent_app_date] => 2011-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28223 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20110196016.pdf [firstpage_image] =>[orig_patent_app_number] => 13018471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8211913 [patent_doc_number] => 20120130060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'Modified antisense oligopeptides with anticancer properties and method of obtaining them' [patent_app_type] => utility [patent_app_number] => 12/931468 [patent_app_country] => US [patent_app_date] => 2011-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5479 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20120130060.pdf [firstpage_image] =>[orig_patent_app_number] => 12931468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6144910 [patent_doc_number] => 20110130443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'Compositions And Methods For Inhibiting Expression Of Factor V Leiden Mutant Gene' [patent_app_type] => utility [patent_app_number] => 13/010300 [patent_app_country] => US [patent_app_date] => 2011-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17713 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20110130443.pdf [firstpage_image] =>[orig_patent_app_number] => 13010300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663748 [patent_doc_number] => 20110313017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'SNALP FORMULATIONS CONTAINING POLYOXAZOLINE-DIALKYLOXYPROPYL CONJUGATES' [patent_app_type] => utility [patent_app_number] => 13/006277 [patent_app_country] => US [patent_app_date] => 2011-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50238 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0313/20110313017.pdf [firstpage_image] =>[orig_patent_app_number] => 13006277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8096039 [patent_doc_number] => 20120083596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'Pharmaceutical Composition' [patent_app_type] => utility [patent_app_number] => 13/006099 [patent_app_country] => US [patent_app_date] => 2011-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 42660 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20120083596.pdf [firstpage_image] =>[orig_patent_app_number] => 13006099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8649521 [patent_doc_number] => 20130035251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-07 [patent_title] => 'miRNA FINGERPRINT IN THE DIAGNOSIS OF WILMS\' TUMOUR' [patent_app_type] => utility [patent_app_number] => 13/519959 [patent_app_country] => US [patent_app_date] => 2010-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 15459 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13519959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6214473 [patent_doc_number] => 20110136891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'Nucleic acid molecules and collections thereof, their application and Identification' [patent_app_type] => utility [patent_app_number] => 12/930018 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 115 [patent_figures_cnt] => 115 [patent_no_of_words] => 19936 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12930018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8443739 [patent_doc_number] => 20120260355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'Method for Evaluating Inhibitory Polynucleotide Efficiency and Efficacy' [patent_app_type] => utility [patent_app_number] => 13/517094 [patent_app_country] => US [patent_app_date] => 2010-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7987 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13517094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10095851 [patent_doc_number] => 09132146 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-15 [patent_title] => 'Furin-knockdown and GM-CSF-augmented (FANG) cancer vaccine' [patent_app_type] => utility [patent_app_number] => 12/973823 [patent_app_country] => US [patent_app_date] => 2010-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 32 [patent_no_of_words] => 17721 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12973823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8482919 [patent_doc_number] => 20120282326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'COMPOSITIONS AND METHODS RELATED TO MIRNA IN DIABETIC CONDITIONS' [patent_app_type] => utility [patent_app_number] => 13/514829 [patent_app_country] => US [patent_app_date] => 2010-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 15793 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13514829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6172310 [patent_doc_number] => 20110197292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'Delivery method' [patent_app_type] => utility [patent_app_number] => 12/926824 [patent_app_country] => US [patent_app_date] => 2010-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15721 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20110197292.pdf [firstpage_image] =>[orig_patent_app_number] => 12926824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8189289 [patent_doc_number] => 08183223 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Method for detecting carcinoma and agent for suppressing carcinoma' [patent_app_type] => utility [patent_app_number] => 12/964464 [patent_app_country] => US [patent_app_date] => 2010-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 13 [patent_no_of_words] => 7317 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/183/08183223.pdf [firstpage_image] =>[orig_patent_app_number] => 12964464 [rel_patent_id] =>[rel_patent_doc_number] =>)